CLINICAL_TRIALS
trial_result
· 2012-06-22
Clinical Trial Update: Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia [Phase 3]
Summary
This trial update summarizes results from a Phase 3 study evaluating the clinical benefit of SEROQUEL XR in adults with schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-06-22